MEDIUM confidence: 100% data completeness, but the composite (54) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Avg target $258 (last qtr, 15 analysts) → $267 (last mo, 3) (+3.5%).
Buy-rated share 48% → 46% over ~3 months (-2pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $2.08 | $2.10 | +1.0% |
| May 2026 | $1.81 | $1.93 | +6.6% |
| Mar 2026 | $2.90 | $3.04 | +4.8% |
| Nov 2025 | $1.88 | $1.96 | +4.3% |
| Aug 2025 | $1.81 | $2.00 | +10.5% |
| May 2025 | $1.76 | $1.85 | +5.1% |
| Mar 2025 | $2.94 | $3.28 | +11.6% |
| Nov 2024 | $1.76 | $1.96 | +11.4% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $8.2B— | $8.7B+5.2% | $7.8B-10.6% | $7.7B-0.5% | $7.8B+1.2% |
| EPS (dil.) | $7.38— | $8.16+10.7% | $7.28-10.8% | $8.79+20.7% | $8.84+0.6% |
| Free Cash Flow | $1.1B— | $699M-39.0% | $1.5B+113.5% | $1.1B-23.7% | $1.1B-7.3% |
| Gross Margin | 44.0% | 42.4%-1.6pp | 42.6%+0.2pp | 46.5%+3.8pp | 46.2%-0.3pp |
| Operating Margin | 17.6% | 17.3%-0.3pp | 16.1%-1.2pp | 18.5%+2.5pp | 18.1%-0.4pp |
| Net Margin | 13.7% | 13.0%-0.7pp | 12.3%-0.7pp | 14.6%+2.3pp | 13.9%-0.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 4.8%/yr (revenue basis).
Base free cash flow $1.2B (avg FY2023–FY2025; latest year $1.1B) · equity value $29.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$23.7M over 180 days (0 open-market buys, 30 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 54 for Williams-Sonoma indicates a neutral outlook, with the stock's strengths and weaknesses balancing out. The company scores high on momentum and profitability, driven by its 29.3% return over the past year and a strong ROE near 58%. However, its value and growth scores are lower due to a P/E of 25.5 and sluggish revenue growth of 1.2%. The short-term score is slightly higher than the long-term score, suggesting some recent positive trends.